Abstract
IFN proteins are a family of lymphokines with anti-viral effects. Several other effects of IFNs have also been described, including enhancement of natural killer (NK) cell activity, enhancement of cytotoxic T-lymphocyte activity, and enhancement of the expression of major histocompatibility complex (MHC) antigens. The latter effects have been characterized as immunomodulatory, whereas the well-known inhibition of growth of malignant cells has been termed anti-proliferative.
This review summarizes the current knowledge of the enhancement of MHC products by IFNs. Whereas the basic methodologies for demonstrating the enhancement are simple and reliable, especially when using flow cytometry (FCM), the biological relevance of this reaction is largely unknown. Based on recent findings, however, we have hypothesized that the above-mentioned diverse effects of IFNs are all-in some way or other-related to the classical anti-viral mechanism. This concept proposes that the MHC-enhancing effect of IFNs is a vital part of the immunological defense against virus infections and an integral part of the anti-viral effects of IFN proteins.
Similar content being viewed by others
Abbreviations
- 2-5A:
-
2′,5′-oligoadenylate
- β2-M:
-
β2-Microglobulin
- dsRNA:
-
double-stranded RNA
- FCM:
-
Flow Cytofluorometry
- IFN:
-
Interferon
- IL-1:
-
Interleukin-1
- IL-2:
-
Interleukin-2
- MHC:
-
Major Histocompatibility Complex
- NK:
-
Natural Killer
References
Hokland M: Immunomodulatory effects of interferons on human mononuclear cells with special reference to the expression of cell surface antigens. Thesis. Acta Path Microbiol Immunol Scand Sect. C, Suppl. 286, 93: 1–35, 1985
Rosa F, Fellous M: The effect of γ-interferon on MHC antigens. Immunol. Today 5: 261–264, 1984
Sen GC: Biochemical pathways in interferon-action. Pharmac Ther 24: 235–257, 1984
Weissman C, Weber H: The interferon genes. Prog Nucl Acid Res Mol Biol 33: 251–300. Cohn WE, Moldave K (eds) Academic Press, 1986
Weissenbach J, Chernajovsky Y, Zeevi M, Shulman L, Soreq H, Nir U, Wallach D, Perricaudet M, Tiollais P, Revel M: Two interferon mRNAs in human fibroblasts: In vitro translation and Escherichia coli cloning studies. Proc Natl Acad Sci USA 77: 7152–7158, 1980
Sehgal PB, Sagar AD: Heterogeneity of poly(I):poly(C)-induced human fibroblast interferon mRNA species. Nature 288: 95–96, 1980
Revel M, Ruggieri R, Zilberstein A: Expression of human IFN-β 2 genes in rodent cells. In: Schellekens H, StewartII WE (eds) The Biology of the Interferon System. Elsevier, Amsterdam, 1985, pp. 207–216
Moore RN, Larsen HS, Horohov DW, Rouse BT: Endogenous regulation of macrophage proliferative expansion by colony-stimulating factor-induced interferon. Science 233: 178–179, 1984
Van Damme J, DeLey M, Opdenakker G, Billiau A, de Somer P, Van Beeumen J: Homogenous interferon-inducing 22k factor is related to endogenous pyrogen and interleukin 1. Nature 314: 266–268, 1985
Zullo JN, Cochran BH, Huang AS, Stiles CD: Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells. Cell 43: 793–799, 1985
Kohase MN, Henriksen-DeStefano D, May LT, Vilcek J, Sehgal PB: Induction of interferon-β 2 by ‘tumor necrosis factor’. A homeostatic mechanism in the control of cell proliferation. Cell 45: 659–663, 1986
Duc-Goiran P, Robert-Galliot B, Lopez J, Chany C: Unusual apparently constitutive interferons and antagonists in human placental blood. Proc Natl Acad Sci USA 82: 5010–5014, 1985
Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J: Systemic Lupus Erythematosus: Presence in human serum of an unusual acid-labile leukocyte interferon. Science 216: 429–430, 1982
Week PK, Apperson S, May L, Stebbing N: Comparison of the anti-viral activities of various cloned human interferon-a subtypes in mammalian cell cultures. J Gen Virol 57: 233–241, 1981
Heron I, Hokland M, Berg K: 13 native HuIFN-a species assessed for immunoregulatory properties. J Interferon Res 3: 231–235, 1983
Ortaldo JR, Herberman RB, Harvey C, Osheroff P, Pan Y-CE, Kelder B, Pestka S: A species of human a-interferon that lacks the ability to boost human natural killer activity. Proc Natl Acad Sci USA 81: 4926–4929, 1984
Hiscott J, Cantell K, Weissman C: Differential expression of human interferon genes. Nucl Acid Res 12: 3727–3731, 1984
Bodmer WF: HLA Today. Hum Immunol 17: 490–503, 1985
Peterson PA, Rask L, Östberg L: 205–1-Microblobulin and the major histocompatibility complex. Adv Cancer Res 24: 115–163, 1977
Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ: The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 38: 287–291, 1984
Kaufman JF, Auffray C, Korman AJ, Shackelford A, Strominger J: The class II molecules of the human and murine major histocompatibility complex. Cell 36: 1–48, 1984
Radka SF, Charron DJ, Brodsky FM: Class II molecules of the Major Histocompatibility Complex considered as differentiation markers. Human Immunol 16: 390–400, 1986
Schwartz RH: The role of gene products of the Major Histocompatibility Complex in T cell activation and cellular interactions. In: Paul WE (ed) Fundamental Immunology, Raven Press, New York, pp. 379–438, 1985
Lindahl P, Leary P, Gresser I: Enhancement of interferon of the expression of surface antigen on murine leukemia L1210 cells. Proc Natl Acad Sci USA 70: 2785–2788, 1973
Carrel S, Schimdt-Kessen A, Giuffre L: Recombinant interferon-gamma can induce the expression of HLA-DR and DC or DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor associated antigens. Eur J Immunol 15: 118–123, 1985
Lindahl P, Peary P, Gresser I: Enhancement of the expression of histocompatibility antigens of mouse lymphoid cells by IFN in vitro. Eur J Immunol 4: 779–784, 1974
Lindahl P, Gresser I, Leary P, Tovey M: Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells. Proc Natl Acad Sci USA 7: 1284–1287, 1976
Heron I, Hokland M, Berg K: Enhanced expression of β2-Microglobulin and HLA antigens on human lymphoid cells by IFN. Proc Natl Acad Sci USA 75: 6215–6218, 1978
Fellous M, Kamoun M, Gresser I, Bono R: Enhanced expression of HLA antigens and β2-Microglobulin on IFN-treated human lymphoid cells. Eur J Immunol 9: 446–449, 1979
Durandy A, Virelizier J-L, Griscelli C: Enhancement by IFN of membrane HLA-antigens in patients with combined immunodeficiency with defective HLA expression. Clin Exp Immunol 52: 173–179, 1983
Attallah AM, Strong DM: Differential effects of Interferon on the MHC expression of human lymphocytes. Enhanced expression of HLA without effect on Ia. Arch Allergy Appl Immunol 60: 101–105, 1979
Hokland M, Heron I, Berg K: Increased expression of β2-Microglobulin and histocompatibility antigens on human lymphoid cells induced by IFN. J IFN Res 1: 483–497, 1981
Dolei A, Ameglio F, Capobianchi MR, Tosi R: Human β-type Interferon enhances the expression and shedding of Ia-like antigens. Comparison to HLA-A,-B,-C and β2-Microglobulin. Anti-viral Res 1: 367–374, 1981
Burrone OR, Milstein C: Control of HLA ABC synthesis and expression in Interferon treated cells. EMBO J 1: 345–349, 1982
Wallach D, Fellous M, Revel M: Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells. Nature 299: 240–245, 1982
Vignaux F, Gresser I: Differential effects of IFN on the expression of H-2K, H-2D and Ia antigens on mouse lymphocytes. J Immunol 118: 721–726, 1977
Imai K, Ng A-K, Glassy MC, Ferrone S: Differential effect of IFN on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: relationship to susceptibility to immune lysis mediated by monoclonal antibodies. J Immunol 127: 505–31, 1981
Basham TY, Bourgeade MF, Creasey AA, Merigan TC: Interferon increases HLA synthesis in melanoma cells: Interferon-resistant and-sensitive lines. Proc Natl Acad Sci USA 79: 3265–3269, 1982
Liao S-K, Kwong PC, Khosravi M, Dent PB: Enhanced expression of melanoma-associated antigens and β2-Microglobulin on cultured human melanoma cells by IFN. J Natl Cancer Inst 68: 19–22, 1982
Pulczynski S, Boesen AM, Myhre Jensen O, Ellegaard J, Hokland P: Immunoelectron microscopy studies on the modulation of CALLA on NALM-6 cells. Leukemia, submitted 1988
Lucero MA, Magdelenat H, Fridman WH, Pouillart P, Billardon C, Billiau A, Cantell K, Falcoff E: Comparison of effects of leukocyte and fibroblast IFN on immunological parameters in cancer patients. Eur J Cancer Clin Oncol 18: 243–247, 1982
Hokland M, Ritz J, Hokland P: Interferon-induced changes in expression of antigens defined by monoclonal antibodies on malignant and non-malignant mononuclear hemato-poietic cells. J Interferon Res 3: 199–209, 1983
Sonnenfeld G, Merullo D, McDevitt HO, Merigan TC: Effect of type I and type II Interferon on murine thymocyte surface antigen expression: induction or selection? Cell Immunol 57: 427–439, 1981
Dolei A, Capobianchi MR, Ameglio F: Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta. Infect Immunit 40: 172–176, 1983
Virelizier JL, Perex N, Arenzana-Seisdedos F, Devos R: Pure interferon gamma enhances class II HLA antigens on human monocyte cell lines. Eur J Immunol 14: 106–108, 1984
Basham T, Merigan TC: Immunoregulation by γ-Interferon? Nature (London) 299: 778–779, 1982
Basham T, Merigan TC: Recombinant Interferon-γ increases HLA-DR synthesis and expression. J Immunol 130: 1491–1494, 1983
Scher MG, Beller DI, Unanue ER: Demonstration of a soluble mediator that induces exudates rich in Ia + macrophages. J Exp Med 152: 1684–1698, 1980
Steeg PS, Moore R, Oppenheim JJ: Regulation of murine macrophage Ia antigen expression by products of activated spleen cells. J Exp Med 152: 1734–1744, 1980
Steinman RN, Noguerira N, Witmer M, Tydings J, Mellman I: Lymphokine enhances the expression and synthesis of Ia antigens on cultures of mouse peritoneal macrophages. J Exp Med 152: 1248–1261, 1980
Beller DI, Ho I: Regulation of macrophage populations. V. Evaluation of the control of macrophage Ia expression in vitro. J Immunol 129: 971–976, 1982
Calamai E, Beller DI, Unanue ER: Regulation of macrophage populations. IV. Modulation of Ia expression in bone marrow derived macrophages. J Immunol 128: 1692–1694, 1982
Prostowsky MB, Ely JM, Beller DI, Eisenber L, Goldman J: Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes. J Immunol 129: 2337–2344, 1982
Steeg P, Moore RN, Johnson HM, Oppenheim JJ: Regulation of murine macrophage Ia antigen expression by a lymphokine with immune Interferon activity. J Exp Med 156: 1780–1793, 1982
King DP, Jones PP: Induction of Ia and H-2 antigen expression on a macrophage cell line by immune IFN. FED Proc 42: 448–449, 1982
Pober JS, Gimbrone AJr, Cotran RS, Reiss CS, Burakoff SJ, Fiers W, Ault KA: Ia expression by vascular endothelium is inducible by activated T cells and by human γ interferon. J Exp Med 157: 1339–1353, 1983
Pober JS, Colins T, Gimbrone M, Cotran R, Gitlin J, Riers W, Clayberger C, Krensky A, Burakoff S, Reiss C: Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 305: 726–729, 1983
Rosa F, Fellous M, Dron M, Tovey MG, Revel M: Presence of an abnormal β2-Microglobulin mRNA in Daudi cells: induction by IFN. Immunogenetics 17: 125–131, 1983
Rosa F, Hata D, Abadie A, Wallach D, Revel M, Fellous M: Differential regulation of HLA-DR mRNAs and cell surface antigens by interferon. EMBO J 2: 1585–1589, 1983
Capkova J, Peknicova J, Hajnicka V, Borecky L: IFN-induced changes in the expression and topography of H-2 antigens and receptors for SRBNC in tumor cells. Folia Biol (Praha) 28: 28–35, 1982
Williams BRG: Biochemical actions. In: Sikora K (ed) Interferon and Cancer. Plenum Press, New York, pp. 33–52, 1983
Johnstone MI, Torrence PF: The role of interferon-induced proteins, double-stranded RNA and 2′5′-oligoadenylate in the interferon mediated inhibition of viral translation. In: Friedman RM (ed) Interferons and interferon inducers. Academic Press, London, pp. 189–201, 1984
Fellous M, Nir U, Wallach D, Merlin G, Rubinstein M, Revel M: Interferon dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells. Proc Natl Acad Sci USA 79: 3082–3086, 1982
Killander D, Lindahl P, Lundin L, Leary P, Gresser I: Relationship between the enhanced expression of histocompatibility antigens on IFN-treated L1210 cells and their position in the cell cycle. Eur J Immunol 6: 56–59, 1976
Pfeffer LM, Wang E, Tamm I: IFN effects on microfilament organization, cellular fibronectin distribution, and cell motility in human fibroblasts. J Cell Biol 85: 9–18, 1980
Pfeffer LM, Tamm I: Effects of α and β IFNs on the size and proliferation of human cells. In: Abstract, The Third Annual International Congress for IFN Research, Miami, FL. November, 1982
Shulman LM, Kamarck ME, Barbosa JA, Ruddle FH: IFN induced surface expression of HLA in LTK-cells transfected with HLA genomic clones. In: Abstracts, The Third Annual International Congress for IFN Research, Miami, FL. November, 1982
Yoshie O, Schmidt H, Reddy ESP, Weissman S, Lengyel P: Mouse Interferons enhance the accumulation of a human HLA RNA and protein in transfected mouse and hamster cells. J Biol Chem 257: 13169–13172, 1982
Hokland M, Hokland P, Heron I, Schlossman SF: Selective effects of α interferon on human T-lymphocyte subsets during mixed lymphocyte cultures. Scand J Immunol 17: 559–576, 1983
Hirsch M-R, Wietzerbin J, Pierres M, Goridis C: Expression of Ia antigens by cultured astrocytes treated with gamma-interferon. Neurosci Lett 41: 199–204, 1983
Fellous M, Bono R, Hyafil F, Gresser I: IFN enhances the amount of membrane-bound beta2-Microglobulin and its release from human Burkitt cells. Eur J Immunol 11: 524–526, 1981
Zinkernagel RM, Doherty PC: Restriction of in vitro T-cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248: 701–702, 1974
Eager KB, Williams J, Breiding D, Pan S, Knowles B, Appella E, Picciardi RP: Expression of histocompatibility antigens H-2K,-D, and-L is reduced in adenovirus-12 transformed mouse cells and is restored by interferon γ. Proc Natl Acad Sci USA 82: 5525–5529, 1985
Tanaka K, Isselbacher KJ, Khoury G, Jay G: Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene. Science 228: 226–230, 1985
Wallich R, Bulbuc N, Hammerling GJ, Katzav S, Selga S, Feldman M: Abrogation of metastatic properties of tumor cells by de novo expression of H-2K antigens following H-2 gene transfection. Nature 325: 301–305, 1985
Sztein MB, Steeg PS, Steihm R, Maun D, Blaese M, Oppenheim JJ: Modulation of human cord blood monocyte DR antigen expression in vitro by lymphokines and Interferon. In: Oppenheim JJ, Cohen S (eds) Interleukins, Lymphokines and Cytokines. Academic Press, New York, pp. 299–305, 1983
Steeg PS, Johnson HM, Oppenheim JJ: Regulation of murine macrophage Ia antigen expression by an immune Interferon-like lymphokine: inhibitory effect of endotoxin. J Immunol 129: 2402–2406, 1982
Unanue ER, Beller DI, Lu CY, Allen PM: Antigen presentation: comments on its regulation and mechanism. J Immunol 132: 1–5, 1984
Bottazzo GF, Pujol-Borrell R, Hanafusl T: Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet ii: 115–118, 1983
Wong GHW, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW: Inducible expression of H-2 and Ia antigens on brain cells. Nature 310: 668–690, 1984
Meuer SC, Schlossman SF, Reinherz EL: Clonal analysis of human cytotoxic T lymphocytes: T4 + and T8 + effector T regions. Proc Natl Acad Sci USA 79: 4395–4399, 1982
Trinchieri G, Santoli D: Anti-viral activity induced by culturing lymphocytes with tumour-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med 147: 1314–1333, 1978
Trinchieri G, Granato D, Perussia B: Interferon-induced resistance of fibroblasts to cytolysis mediated by natural killer cells: specificity and mechanism. J Immunol 126: 335–340, 1981
Nathan CF, Murray HW, Wiebe ME, Rubin BY: Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158: 670–689, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hokland, M., Basse, P., Justesen, J. et al. IFN-induced modulation of histocompatibility antigens on human cells. Cancer Metast Rev 7, 193–207 (1988). https://doi.org/10.1007/BF00047751
Issue Date:
DOI: https://doi.org/10.1007/BF00047751